AI & Deep Learning
Sub brand
Back to top


Date: Tuesday, October 25, 2022
Time: 8:00am - 9:00am PT
Duration: 1 hour

In the last decade, there have been dramatic advances in the field of computer-aided drug discovery. Researchers can now better understand causal biology, more effectively search through chemical space, and design de novo molecules that aim to treat disease.

In this webinar, we will provide an inside look into:
  • How Schrodinger uses NVIDIA-powered solutions to drive their in-silico drug discovery platform and recent NVIDIA optimizations to the Schrodinger suite.
  • How organizations can easily implement the Schrodinger platform at scale, on premises, or in the cloud.
Join us after the webinar for a live Q&A session.

Webinar Registration


You will receive an email with instructions on how to join the webinar shortly.


Content goes here


content goes here

main image description


Content goes here


DGX Station Datasheet

Get a quick low-down and technical specs for the DGX Station.
DGX Station Whitepaper

Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.
DGX Station Whitepaper

Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.


Content goes here


Sathesh Bhat

Ph.D., Executive Director in the Drug Discovery Group, Schrodinger

Sathesh Bhat joined Schrödinger in 2011. He is responsible for overseeing computational chemistry efforts on internal and partnered drug discovery programs at Schrödinger. Previously, Sathesh worked at both Merck and Eli Lilly leading computational efforts in several drug discovery programs. He obtained his Ph.D. from McGill University, which involved developing structure-based methods to predict binding free energies. Sathesh has co-authored multiple patents and publications and continues to publish on a wide variety of topics in computational chemistry.

Rory Kelleher

Global Director and Head of Business Development for Healthcare, NVIDIA

Rory Kelleher is responsible for NVIDIA’s worldwide go-to-market strategy for bringing accelerated computing and artificial intelligence into life sciences, drug discovery, and healthcare markets. He leads a team of professionals operating at the intersection of science, technology and business to align with industry leaders and apply transformational computational approaches across the healthcare and life sciences landscape. Kelleher joined NVIDIA in 2016 leading the Healthcare business for the Eastern US, helping organizations tap into the NVIDIA ecosystem and expertise to adopt, develop, and deploy intelligent and accelerated applications. Prior to NVIDIA, Kelleher spent a decade in business development and sales leadership positions at technology firms Cisco Systems and EMC Corp.

Presenter 3 Name

Presenter 3 Title


Presenter 4 Name

Job Title 4

Presenter 4 Bio

Other Speakers


Job Title.
Name 2

Job Title.
Name 3

Job Title.

Content Title

Content here


Webinar: Description here

Date & Time: Wednesday, April 22, 2018